Clinical Trial
-
Biologics
Ortho Regenerative Technologies Initiates Patients Recruitment For Its U.S. Phase I/II Rotator Cuff Tear Repair Clinical Trial
Contracting procedures completed for 6 of the 10 clinical trial sites5 sites fully activated, with ongoing patients’ screening and recruitment…
Read More » -
Spine
Clinical Trial to Test Replacement Devices for Two-Level Symptomatic Cervical Disc Disease
NEW YORK, June 1, 2022 /PRNewswire/ — A multicenter, prospective, randomized controlled trial is designed to assess the effectiveness of three different disc replacement…
Read More » -
Biologics
First Subjects Randomized and Dosed in the U.S. under Phase III Pivotal Trial for the Treatment of Pain Associated with Knee OA
Ongoing trial to assess the potential of Zilosul™ to address unmet medical need in OA which affects more than 72 million…
Read More » -
Spine
Spineart-100 U.S. Patients Treated In The Single Level IDE Clinical Trial Of BAGUERA®C Cervical Disc Prosthesis
LAGUNA HILLS, Calif., April 21, 2022 /PRNewswire/ — Spineart USA Inc. announced today that surgery has been performed on 100 patients in the single-level U.S.…
Read More » -
Biologics
Ortho Regenerative Technologies Enters Into A Material Transfer Agreement With A Global Strategic Medical Company For Its Ortho-R Rotator Cuff Tear Repair Phase I/II U.S. Clinical Trial
MONTREAL, Feb. 7, 2022 /PRNewswire/ – Ortho Regenerative Technologies Inc. (CSE: ORTH) (OTC: ORTIF) (“Ortho” or the “Company“), a clinical-stage orthobiologics company focused on…
Read More » -
Spine
Mainstay Medical Announces Publication of Two-Year Patient Outcomes Data from ReActiv8-B Clinical Trial Demonstrating Long-Term Efficacy of ReActiv8® Restorative Neurostimulation™
Data shows compelling efficacy and safety, as well as improvement on all key measures of pain and disability as compared…
Read More » -
Biologics
Ortho Regenerative Technologies Receives Clinical Hold Letter From the U.S. FDA
Additional CMC related data and characterization requested by the FDACompany confident of providing requested information over the coming weeksPhase I/II…
Read More » -
Neuro
ADR Spinal Restoration Center Opens Up 2-Level prodisc® and 1-Level Synergy Disc® Clinical Trials in Los Angeles
LOS ANGELES (PRWEB) MAY 21, 2021 Those suffering from painful degenerative or herniated discs in their necks might find relief in…
Read More » -
Spine
Synergy Disc® Announces Enrollment of First Patient in US IDE Clinical Trial
January 29, 2021 LOUISVILLE, Colo.–(BUSINESS WIRE)–Synergy Disc Replacement Ltd., a Colorado-based spinal medical device company and wholly owned subsidiary of…
Read More » -
Recon
LimaCorporate Announces FDA Approval for an Ide Study on Smr Stemless Reverse Shoulder System
UDINE, Italy, Nov. 19, 2020 /PRNewswire/ — LimaCorporate is proud to announce that the U.S. Food and Drug Administration (FDA) has approved the…
Read More » -
Biologics
Bioventus Receives Authorization to Proceed Under Investigational New Drug Application for Clinical Trial of Placental Tissue Particulate (PTP-001) for the Treatment of Knee OA
November 18, 2020 DURHAM, N.C.–(BUSINESS WIRE)–Bioventus, a leader in Solutions For Innovative Healing, received authorization to proceed under its investigational…
Read More »